EMCDDA Home
  • EN
Search

Figure PDU-2. Estimates of the prevalence of injecting drug use (rate per 1000 population aged 15 to 64), studies from 2001 to 2005

Notes:

Methods of estimation are abbreviated: CR=Capture-recapture; TM =Treatment multiplier; PM = Police multiplier; MI = Multivariate indicator; TP= Truncated Poisson; CM = Combined methods; MM= Mortality multiplier; MME = Multiplier Method.

The symbol indicates a point estimate, a bar indicates an uncertainty interval, which can be either a 95%-confidence interval or an interval based on sensitivity analysis (see Table PDU-3).

Target groups may vary slightly owing to different methods and data sources; therefore comparisons should be made with caution.

Mortality and HIV multipliers are assumed to give estimates of (mainly current) injecting drug use, which is only part of problem drug use.

* - Estonia: Original age range of study was 15-44, rates have been adjusted to 15-64.

Links:

SB2006: Figure PDU-02 part (i)

For more details see Tables PDU-1 to PDU-3 in the 2007 Statistical Bulletin.

See also EMCDDA project (2003): National prevalence estimates of problem drug use in the European Union, 1995–2000, CT.00.RTX.23, EMCDDA, Lisbon, coordinated by the Institut für Therapieforschung, Munich (http://www.emcdda.eu.int/?nnodeid=1372).

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

National Focal Points.

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 23 November 2007